// App-Quantinova.ai

3343 : Targeting the Lin28A/B axis reverts stem cell-like phenotype and tumor-initiating properties in prostate cancer

Researchers

Presenter

  • Domenico Albino

Principal Investigators

  • Gianluca Civenni

  • Cecilia Dallavalle

  • Martina Roos

  • Hartmut Jahns

  • Jonathan Hall

  • Giuseppina M. Carbone

  • Carlo V. Catapano

Medical Centers

  • Institute of Oncology Research - IOR, Bellinzona, Switzerland

  • Institute of Pharmaceutical Sciences, ETHZ, Zurich, Switzerland.

Locations

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • ETS homologous factor

  • ETS transcription factor ERG

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved